Response to: 'Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: A critical appraisal'

K. Rosén; M. Maurer; H. Hsieh; S. Saini; C. Grattan; A. Gimenéz-Arnau; S. Agarwal; R. Doyle; J. Canvin; A. Kaplan; T. Casale

doi:10.1111/bjd.13075

Response to: 'Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: A critical appraisal'

K. Rosén, M. Maurer, H. Hsieh, S. Saini, C. Grattan, A. Gimenéz-Arnau, S. Agarwal, R. Doyle, J. Canvin, A. Kaplan, T. Casale

School of Medicine

Research output: Contribution to journal › Comment/debate

Original language	English (US)
Pages (from-to)	15-16
Number of pages	2
Journal	British Journal of Dermatology
Volume	171
Issue number	1
DOIs	https://doi.org/10.1111/bjd.13075
State	Published - Jan 1 2014

ASJC Scopus subject areas

Dermatology

Cite this

Rosén, K., Maurer, M., Hsieh, H., Saini, S., Grattan, C., Gimenéz-Arnau, A., Agarwal, S., Doyle, R., Canvin, J., Kaplan, A., & Casale, T. (2014). Response to: 'Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: A critical appraisal'. British Journal of Dermatology, 171(1), 15-16. https://doi.org/10.1111/bjd.13075

Response to : 'Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: A critical appraisal'. / Rosén, K.; Maurer, M.; Hsieh, H.; Saini, S.; Grattan, C.; Gimenéz-Arnau, A.; Agarwal, S.; Doyle, R.; Canvin, J.; Kaplan, A.; Casale, T.

In: British Journal of Dermatology, Vol. 171, No. 1, 01.01.2014, p. 15-16.

Research output: Contribution to journal › Comment/debate

@article{8ae55c50d6b046a6b0354de2bece48d1,

title = "Response to: 'Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: A critical appraisal'",

author = "K. Ros{\'e}n and M. Maurer and H. Hsieh and S. Saini and C. Grattan and A. Gimen{\'e}z-Arnau and S. Agarwal and R. Doyle and J. Canvin and A. Kaplan and T. Casale",

year = "2014",

month = jan

day = "1",

doi = "10.1111/bjd.13075",

language = "English (US)",

volume = "171",

pages = "15--16",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Response to

T2 - 'Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: A critical appraisal'

AU - Rosén, K.

AU - Maurer, M.

AU - Hsieh, H.

AU - Saini, S.

AU - Grattan, C.

AU - Gimenéz-Arnau, A.

AU - Agarwal, S.

AU - Doyle, R.

AU - Canvin, J.

AU - Kaplan, A.

AU - Casale, T.

PY - 2014/1/1

Y1 - 2014/1/1

UR - http://www.scopus.com/inward/record.url?scp=84904903875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904903875&partnerID=8YFLogxK

U2 - 10.1111/bjd.13075

DO - 10.1111/bjd.13075

M3 - Comment/debate

C2 - 25066290

AN - SCOPUS:84904903875

VL - 171

SP - 15

EP - 16

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 1

ER -

Access to Document

10.1111/bjd.13075